APP and Cognitive impairment: The present results showed that FLX reduced the deposition of beta amyloid in the hippocampus of APP/PS1 mice, consistent with previous findings [19, 20, 67, 68], suggesting that the ability of FLX to alleviate cognitive deficits in APP/PS1 mice may depend on decreasing the aggregation of beta amyloid in the hippocampus.